Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
12
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Girao Tiago | VP & Chief Financial Officer | 8 | $0 | $0 | 2018-07-25 |
| Hawkins Richard J | Director | 7 | $0 | $0 | 2018-07-25 |
| HEDRICK MARC H | President and CEO | 8 | $0 | $0 | 2018-07-25 |
| HARRIS JOHN DAVID | VP and GM Cell Therapy | 5 | $0 | $0 | 2017-11-28 |
| Naughton Gail K | Director | 4 | $0 | $0 | 2017-11-28 |
| RICKEY DAVID | Director | 4 | $0 | $0 | 2017-11-28 |
| LYONS GARY A | Director | 4 | $0 | $0 | 2017-11-28 |
| LAPOINTE ANTHONY GREGG | Director | 1 | $0 | $0 | 2017-05-22 |
| Marino Mark | Chief Medical Officer | 2 | $0 | $0 | 2017-03-08 |
| HAYDEN JEREMY B. | General Counsel & VP of BD | 2 | $0 | $0 | 2017-03-08 |
| MARTELL RON | Director | 1 | $0 | $0 | 2017-01-26 |
| HAWRAN PAUL W | Director | 1 | $0 | $0 | 2017-01-26 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Girao Tiago | VP & Chief Financial Officer | X Exercise deriv | 2018-07-25 | 2018-07-27 | 1,050 | — | $0 | 1,050 | SEC↗ |
| Girao Tiago | VP & Chief Financial Officer | X Exercise deriv | 2018-07-25 | 2018-07-27 | 1 | — | $0 | 0 | SEC↗ |
| Girao Tiago | VP & Chief Financial Officer | X Exercise deriv | 2018-07-25 | 2018-07-27 | 1 | — | $0 | 1 | SEC↗ |
| HEDRICK MARC H | President and CEO | X Exercise deriv | 2018-07-25 | 2018-07-27 | 35 | — | $0 | 0 | SEC↗ |
| HEDRICK MARC H | President and CEO | X Exercise deriv | 2018-07-25 | 2018-07-27 | 36,750 | — | $0 | 36,750 | SEC↗ |
| HEDRICK MARC H | President and CEO | X Exercise deriv | 2018-07-25 | 2018-07-27 | 35 | — | $0 | 35 | SEC↗ |
| Hawkins Richard J | Director | X Exercise deriv | 2018-07-25 | 2018-07-27 | 10 | — | $0 | 35 | SEC↗ |
| Hawkins Richard J | Director | X Exercise deriv | 2018-07-25 | 2018-07-27 | 10,500 | — | $0 | 10,500 | SEC↗ |
| Hawkins Richard J | Director | X Exercise deriv | 2018-07-25 | 2018-07-27 | 10 | — | $0 | 0 | SEC↗ |
| LYONS GARY A | Director | X Exercise deriv | 2017-11-28 | 2018-02-09 | 1 | — | $0 | 0 | SEC↗ |
| LYONS GARY A | Director | X Exercise deriv | 2017-11-28 | 2018-02-09 | 1 | — | $0 | 1 | SEC↗ |
| LYONS GARY A | Director | X Exercise deriv | 2017-11-28 | 2018-02-09 | 1,800 | — | $0 | 1,800 | SEC↗ |
| Girao Tiago | VP & Chief Financial Officer | X Exercise deriv | 2017-11-28 | 2017-11-29 | 1 | — | $0 | 0 | SEC↗ |
| Girao Tiago | VP & Chief Financial Officer | X Exercise deriv | 2017-11-28 | 2017-11-29 | 1 | — | $0 | 1 | SEC↗ |
| Girao Tiago | VP & Chief Financial Officer | X Exercise deriv | 2017-11-28 | 2017-11-29 | 1,800 | — | $0 | 1,800 | SEC↗ |
| HARRIS JOHN DAVID | VP and GM Cell Therapy | X Exercise deriv | 2017-11-28 | 2017-11-29 | 1 | — | $0 | 1 | SEC↗ |
| HARRIS JOHN DAVID | VP and GM Cell Therapy | X Exercise deriv | 2017-11-28 | 2017-11-29 | 1 | — | $0 | 0 | SEC↗ |
| HARRIS JOHN DAVID | VP and GM Cell Therapy | X Exercise deriv | 2017-11-28 | 2017-11-29 | 1,800 | — | $0 | 1,800 | SEC↗ |
| Hawkins Richard J | Director | X Exercise deriv | 2017-11-28 | 2017-11-29 | 3 | — | $0 | 0 | SEC↗ |
| Hawkins Richard J | Director | X Exercise deriv | 2017-11-28 | 2017-11-29 | 5,400 | — | $0 | 5,400 | SEC↗ |
| Hawkins Richard J | Director | X Exercise deriv | 2017-11-28 | 2017-11-29 | 3 | — | $0 | 3 | SEC↗ |
| HEDRICK MARC H | President and CEO | X Exercise deriv | 2017-11-28 | 2017-11-29 | 16,200 | — | $0 | 16,200 | SEC↗ |
| HEDRICK MARC H | President and CEO | X Exercise deriv | 2017-11-28 | 2017-11-29 | 9 | — | $0 | 9 | SEC↗ |
| HEDRICK MARC H | President and CEO | X Exercise deriv | 2017-11-28 | 2017-11-29 | 9 | — | $0 | 0 | SEC↗ |
| Naughton Gail K | Director | X Exercise deriv | 2017-11-28 | 2017-11-29 | 1 | — | $0 | 1 | SEC↗ |
| Naughton Gail K | Director | X Exercise deriv | 2017-11-28 | 2017-11-29 | 1 | — | $0 | 0 | SEC↗ |
| Naughton Gail K | Director | X Exercise deriv | 2017-11-28 | 2017-11-29 | 1,800 | — | $0 | 1,800 | SEC↗ |
| RICKEY DAVID | Director | X Exercise deriv | 2017-11-28 | 2017-11-29 | 6 | — | $0 | 0 | SEC↗ |
| RICKEY DAVID | Director | X Exercise deriv | 2017-11-28 | 2017-11-29 | 6 | — | $0 | 6 | SEC↗ |
| RICKEY DAVID | Director | X Exercise deriv | 2017-11-28 | 2017-11-29 | 10,800 | — | $0 | 10,800 | SEC↗ |
| LAPOINTE ANTHONY GREGG | Director | A Award deriv | 2017-05-22 | 2017-05-24 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Girao Tiago | VP & Chief Financial Officer | A Award deriv | 2017-03-08 | 2017-03-10 | 42,000 | — | $0 | 42,000 | SEC↗ |
| HARRIS JOHN DAVID | VP and GM Cell Therapy | A Award deriv | 2017-03-08 | 2017-03-10 | 42,000 | — | $0 | 42,000 | SEC↗ |
| HAYDEN JEREMY B. | General Counsel & VP of BD | A Award deriv | 2017-03-08 | 2017-03-10 | 42,000 | — | $0 | 42,000 | SEC↗ |
| HEDRICK MARC H | President and CEO | A Award deriv | 2017-03-08 | 2017-03-10 | 130,200 | — | $0 | 130,200 | SEC↗ |
| Marino Mark | Chief Medical Officer | A Award deriv | 2017-03-08 | 2017-03-10 | 42,000 | — | $0 | 42,000 | SEC↗ |
| Girao Tiago | VP & Chief Financial Officer | A Award deriv | 2017-03-08 | 2017-03-17 | 31,100 | — | $0 | 31,100 | SEC↗ |
| HARRIS JOHN DAVID | VP and GM Cell Therapy | A Award deriv | 2017-03-08 | 2017-03-17 | 31,100 | — | $0 | 31,100 | SEC↗ |
| HAYDEN JEREMY B. | General Counsel & VP of BD | A Award deriv | 2017-03-08 | 2017-03-17 | 31,100 | — | $0 | 31,100 | SEC↗ |
| HEDRICK MARC H | President and CEO | A Award deriv | 2017-03-08 | 2017-03-17 | 96,350 | — | $0 | 96,350 | SEC↗ |
| Marino Mark | Chief Medical Officer | A Award deriv | 2017-03-08 | 2017-03-17 | 31,100 | — | $0 | 31,100 | SEC↗ |
| MARTELL RON | Director | A Award deriv | 2017-01-26 | 2017-01-27 | 50,000 | — | $0 | 50,000 | SEC↗ |
| RICKEY DAVID | Director | A Award deriv | 2017-01-26 | 2017-01-27 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Naughton Gail K | Director | A Award deriv | 2017-01-26 | 2017-01-27 | 25,000 | — | $0 | 25,000 | SEC↗ |
| HAWRAN PAUL W | Director | A Award deriv | 2017-01-26 | 2017-01-27 | 25,000 | — | $0 | 25,000 | SEC↗ |
| LYONS GARY A | Director | A Award deriv | 2017-01-26 | 2017-01-27 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Hawkins Richard J | Director | A Award deriv | 2017-01-26 | 2017-01-27 | 25,000 | — | $0 | 25,000 | SEC↗ |